Abstract Background In the United States, mifepristone is available for medical abortion (for
use with misoprostol) only with Risk Evaluation and Mitigation Strategy (REMS) restrictions …

Background: Since 2016, abortion care has undergone several important changes,
particularly related to the provision of medical abortion using mifepristone. We aimed to …

On June 24, 2022, the US Supreme Court overturned Roe v. Wade, which marked a further
restriction on women's abortion rights in the US. It has sparked a wide range of societal …

Induction of labour when no live birth is anticipated presents a number of unique
considerations for members of the healthcare team. The main indication for Induction of …

Objectives Mifepristone became available in Canada in 2017. Updated national guidelines
recommend its off-label use for second/third-trimester medical abortion (STMA/TTMA) by …

Background Content on abortion history and methods is notably absent from many health
care education programs in Canada. A team of multi-disciplinary professionals and …

Purpose Under some circumstances, individuals choose to undergo pregnancy termination
for foetal anomalies in the second half of pregnancy. This report provides objective …

Rheumatic diseases affect women during their reproductive years. Many women with
rheumatic diseases become pregnant; some undergo pregnancy termination. However …

Background The shifting landscape of abortion care from a hospital-only to a distributed
service including primary care has implications for how to identify abortion cohorts for …

Introducción: Desde el punto de vista de la Salud Pública, el aborto incompleto se ha venido
trasformando en un problema de salud, por lo que se estima que a nivel global se da …